Medical management of limited-stage Hodgkin lymphoma
High priority
Your appointment may be a high priority if:
-
You are due to undergo curative systemic treatment for limited-stage Hodgkin lymphoma. In these cases, your doctor may decide to change your planned regimen to a less myelosuppressive one. You may also receive prophylactic growth factors to help boost your immune system and reduce the risk of neutropenia. Appointments between scheduled treatments are likely to be conducted via telephone
- You are due to undergo curative radiotherapy for limited-stage disease
- You are receiving treatment as part of a clinical trial
Medical management of advanced Hodgkin lymphoma
High priority
Your appointment may be a high priority if:
-
You are due to undergo curative systemic treatment for advanced Hodgkin lymphoma. In these cases, your doctor may decide to change your planned regimen to a less myelosuppressive one. Appointments between scheduled treatments are likely to be conducted via telephone. If you are being treated with a chemotherapy regimen that includes bleomycin, you doctor may wish you to have a positron emission tomography scan after two cycles of treatment; if the scan shows that your cancer has responded well to treatment, your regimen may then be adjusted to remove the bleomycin. This means that you can then safely receive prophylactic growth factors to help boost your immune system and reduce the risk of neutropenia
- You are receiving treatment as part of a clinical trial
Medical management of relapsed Hodgkin lymphoma
High priority
Your appointment may be a high priority if:
-
You are scheduled to receive high-dose chemotherapy with autologous stem cell support for relapsed Hodgkin lymphoma
Medium priority
Your appointment may be a medium priority if:
-
You are scheduled to undergo maintenance therapy with brentuximab vedotin
- You are scheduled to receive palliative radiotherapy
- You are scheduled to receive palliative systemic therapy
